DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Bressler NM, Odia I, Maguire M. et al.
Association between change in visual acuity and change in central subfield thickness during treatment of diabetic macular edema in participants randomized to aflibercept, bevacizumab, or ranibizumab: a post hoc analysis of the protocol T randomized clinical trial.
JAMA Ophthalmol 2019;
DOI: 10.1001/jamaophthalmol.2019.1963.
We do not assume any responsibility for the contents of the web pages of other providers.